Pfizer $23.85 Million Settlement Resolves Allegations That Company Used Foundation To Cover Medicare Co-Pays

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Pfizer $23.85 Million Settlement Resolves Allegations That Company Used Foundation To Cover Medicare Co-Pays

Dennis Tosh

June 13, 2018 at 06:50 PM EST

Pfizer Inc. agreed to pay $23.85 million to resolve False Claims Act allegations that it used a foundation as a conduit to pay the co-pays of Medicare patients taking three Pfizer drugs, the Department of Justice (DOJ) announced May 24. The government alleged that through the foundation Pfizer covered the co-pay obligations of Medicare patients taking Sutent and Inlyta, used ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Pfizer $23.85 Million Settlement Resolves Allegations That Company Used Foundation To Cover Medicare Co-Pays

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT